<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4331</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2022.14215</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Pharmacovigilance in India: Do Not Take a Chill Pill&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agrawal</surname><given-names>Sanjana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dayama</surname><given-names>Sonal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Galhotra</surname><given-names>Abhiruchi</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>16</day><month>01</month><year>2022</year></pub-date><volume>)</volume><issue/><fpage>93</fpage><lpage>96</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Pharmacovigilance is also often understood as Drug Safety. For drug safety, Adverse Drug Reaction (ADR) must be monitored throughout the life of the drug, from its development, clinical trials, and post-approval. The discipline of Pharmacovigilance has gained its due importance in India recently in the last 10 to 15 years. The importance of pharmacovigilance increases even more in the pandemic situation. Numerous drugs are being used empirically according to experience and availability to treat Covid-19. The pandemic is an insight to regulate the highly unregulated drug distribution system. The system can be strengthened by training of human resource, public-private partnerships, legislation, communication, research and innovation Pharmacovigilance has witnessed substantial development over the years, yet there is a need for a practical revolutionary roadmap to tackle all the hindrances to fortify its symphonic functioning. The public confidence around the efficiency of Pharmacovigilance will build when people have access to good-quality and safe medicines and a suitable system for the distribution of medicines that have cleared Pharmacovigilance.&#13;
</p></abstract><kwd-group><kwd>Pharmacovigilance</kwd><kwd> Adverse side effects</kwd><kwd> Covid 19</kwd><kwd> Challenges</kwd><kwd> Recommendations</kwd><kwd> Public health professional</kwd></kwd-group></article-meta></front></article>
